33rd ICPE: Pharmacoepidemiologic Considerations for Biologics and Biosimilars

Nancy A. Dreyer, FISPE, QuintilesIMS

Thijs Giezen, Foundation Pharmacy for Hospitals in Haarlem

Jaclyn L. F. Bosco, QuintilesIMS

Gianluca Trifirò, University of Messina and Erasmus Medical Center

Brian D. Bradbury, Amgen, Inc.

Components visible upon registration.